Ibiglustat
| CAS No. | 1401090-53-6 | Cat. No. | BCP20857 |
| Name | Ibiglustat | ||
| Synonyms | Venglustat;GZ-402671; GZ402671; GZ402671; SAR402671; SAR-402671; SAR 402671; Genz-682452-AA;GZ-452; Genz-682452; | ||
| Formula | C20H24FN3O2S | M. Wt | 389.49 |
| Description | Ibiglustat, also known as GZ402671, GZ-452; Genz-682452 and SAR402671, is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. Ibiglustat blocks the formation of glucosylceramide (GL-1), a key intermediate in the synthesis of GL-3. Ibiglustat is potentially useful for treating Fabry disease. Fabry disease is a rare lysosomal storage disorder, which results in abnormal tissue deposits of a particular fatty substance called globotriaosylceramide (GL-3 or Gb3) throughout the body. | ||
| Related Products | 1629063-78-0（Ibiglustat succinate） | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.